Nurse Practitioner, Family · Detroit, MI
NPI
1487037099
Since 2015
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
4160 John R St Ste 615
Detroit, MI, 48201
Phone (313) 745-4195
Groups this clinician bills Medicare through
Medicare paid, 2024
$7,460
119 services
Medicare patients, 2024
87
Average age 64
Drug cost, 2024
$285K
1,765 prescriptions
Company payments, 2025
$1,161
From 14 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Sharlet S Geevarughese was code 99213 (office e&m - established), 55 times for 38 patients. In total Sharlet S Geevarughese billed 119 services in 6 codes, and Medicare paid $7,460.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-01-09.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 55 | 38 | $52.31 | $2,877 |
| 99204 Office E&M - New | Office | 27 | 27 | $92.90 | $2,508 |
| 99203 Office E&M - New | Office | 19 | 19 | $52.26 | $993 |
| 99214 Office E&M - Established | Office | 12 | 12 | $76.12 | $913 |
By year: 2022 $12K for 196 services; 2023 $7,641 for 126 services; 2024 $7,460 for 119 services.
Medicare prescription drug claims, 2024
In 2024, the drug Sharlet S Geevarughese prescribed most often to Medicare patients was Gavilyte-G (Peg3350/Sod Sulf,bicarb,cl/Kcl), with 654 prescriptions and refills. In total Sharlet S Geevarughese wrote 1,765 Medicare prescriptions that cost $285K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Gavilyte-G Peg3350/Sod Sulf,bicarb,cl/Kcl | 654 | 654 | 614 | $11K |
| Famotidine Generic | 231 | 477 | 125 | $4,539 |
| Omeprazole Generic | 177 | 356 | 80 | $2,694 |
| Peg-3350 And Electrolytes Peg3350/Sod Sulf,bicarb,cl/Kcl | 162 | 162 | 149 | $2,677 |
| Dicyclomine Hcl Generic | 121 | 183 | 45 | $2,769 |
| Linzess Linaclotide | 87 | 138 | 38 | $71K |
| Pantoprazole Sodium Generic | 39 | 87 | 21 | $349 |
| Ondansetron Odt Ondansetron | 34 | 34 | 20 | $824 |
| Gavilyte-C Peg3350/Sod Sulf,bicarb,cl/Kcl | 28 | 28 | 25 | $459 |
| Peg 3350-Electrolyte Sodium Chloride/Nahco3/Kcl/Peg | 20 | 20 | 20 | $374 |
| Mesalamine Generic | 15 | 23 | Under 11 | $16K |
| Metronidazole Generic | 15 | 15 | 15 | $153 |
| Loperamide Loperamide Hcl | 14 | 20 | Under 11 | $169 |
| Golytely Peg3350/Sod Sulf,bicarb,cl/Kcl | 13 | 13 | 13 | $254 |
| Propranolol Hcl Generic | 13 | 35 | Under 11 | $228 |
Brand drugs: 286 claims; generic drugs: 1,479 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Sharlet S Geevarughese $1,161 ($1,161 in general payments such as food, travel and fees) from 14 companies. The largest payer was Abbvie Inc. with $233.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 5 | $233 |
| Janssen Biotech, Inc. JNJ | 7 | $210 |
| QOL Medical, LLC | 2 | $137 |
| Madrigal Pharmaceuticals MDGL | 1 | $121 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 4 | $110 |
| Ardelyx, Inc. ARDX | 1 | $107 |
| AstraZeneca Pharmaceuticals LP AZN | 1 | $68.49 |
| Pfizer Inc. PFE | 2 | $42.12 |
| Genzyme Corporation SNY | 1 | $34.32 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 1 | $21.38 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.